
Megaplat 50mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Megaplat 50mg Injection
Colon and rectal cancer treatment utilizes Platin 50mg Injection, a medication that inhibits or reduces cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdosing can lead to severe adverse reactions. While benefits may take weeks or months to manifest, discontinue only upon medical advice. Common side effects include nausea, tiredness, vomiting, and diarrhea. Platin 50mg Injection can lower blood cell counts (red and white), increasing infection risk. Serious allergic reactions (e.g., lip sores, mouth ulcers, rash, itching, breathing difficulty) necessitate immediate medical attention. Regular blood tests monitor blood cell levels, heart, liver function, and uric acid. Prior to treatment, disclose any heart, liver, or kidney conditions, and all medications, including antibiotics, to your doctor; drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect; sperm preservation should be discussed with your physician. Dizziness is a possibility; avoid driving after administration.
Primary Ingredients of Megaplat 50mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Megaplat 50mg Injection
Colorectal cancer
Major Benefits of Megaplat 50mg Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
Common Side effects of Megaplat 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Megaplat 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Megaplat 50mg Injection works:
Oncoplat 50mg Injection, an anticancer agent, disrupts the genetic makeup (DNA and RNA) of malignant cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Megaplat 50mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Megaplat 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical counsel.
Breast feedingUNSAFE
Administration of Megaplat 50mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.
DrivingUNSAFE
The administration of Megaplat 50mg Injection, along with Oxaliplatin treatment, can induce side effects such as dizziness, nausea, vomiting, and other neurological symptoms impacting ambulation. These effects may impair driving ability.
KidneyCAUTION
Exercise caution when administering Megaplat 50mg Injection to individuals with severe renal impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Megaplat 50mg Injection use in such patients is limited. Dosage alteration is not advised for patients exhibiting mild to moderate kidney dysfunction.
LiverCAUTION
Exercise caution when administering Megaplat 50mg Injection to individuals with hepatic impairment; dosage modification may be necessary. Seek medical advice.
What if you forget to take Megaplat 50mg Injection :
Omit a Megaplat 50mg Injection dose? Seek medical advice immediately.
Facts to Know About Megaplat 50mg Injection
Label | Value |
---|---|
Chemical Category | Platinum Equivalents |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Action Class | Platinum-based Anticancer Agents |